Jul 28, 2020 7:00am EDT NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic
Jun 29, 2020 7:00am EDT NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients
Jun 02, 2020 4:26pm EDT NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference